Upload

Loading...

Ajay Kirtane, MD, SM Discusses FAME 2 Trial Results with SCAI President

836 views

Loading...

Loading...

Transcript

The interactive transcript could not be loaded.

Loading...

Loading...

Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Sep 5, 2012

Ajay Kirtane, MD, SM, FSCAI, and SCAI President J. Jeffrey Marshall, MD, FSCAI discuss the FAME 2 trial, in which FFR was performed on every patient to confirm that "hemodynamically significant" (or "tight") blockages in their coronary arteries were limiting blood flow. The patients with hemodynamically significant blockages were then randomized to PCI plus the best medications available or medications alone.

Read the SCAI statement on FAME 2 at http://www.scai.org/Press/detail.aspx...

  • Category

  • License

    • Standard YouTube License

Loading...

When autoplay is enabled, a suggested video will automatically play next.

Up Next


Sign in to add this to Watch Later

Add to